Physician profile
Naomi E Olson
NPI 1356878243
$862.55
in general payments reported to CMS, 2019-2025
16 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $334 · 2023: $114 · 2024: $145 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $161.77 | 2022-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.04 | 2021-2024 | Tradjenta, Jardiance, Synjardy |
| Novo Nordisk INC | $103.08 | 2022-2025 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $90.15 | 2021-2022 | |
| Boston Scientific Corporation | $55.09 | 2023-2025 | Watchman Access System |
| Pfizer INC. | $49.49 | 2022-2025 | |
| Lilly USA, LLC | $44.82 | 2022-2024 | Mounjaro |
| Astellas Pharma US INC | $42.90 | 2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $36.72 | 2025 | Breztri |
| Abbott Laboratories | $33.88 | 2021-2025 | Freestyle Libre 3 |
| Electromed, INC. | $27.03 | 2022 | |
| Abbvie INC. | $25.77 | 2024 | |
| Welch Allyn | $25.31 | 2021 | |
| Baxter Healthcare | $25.31 | 2022 | |
| Merck Sharp & Dohme LLC | $12.55 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naomi Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.